Abstract
Stereotactic radiosurgery is indicated for residual or recurrent functioning and nonfunctioning pituitary adenomas, with a high rate of tumor control and hormone remission. A higher margin dose is required to achieve endocrine remission in functioning adenomas. The rate of endocrine remission after radiosurgery appears faster than that achieved with fractionated radiation therapy. Fewer complications are found in patients who receive radiosurgery. The most frequent complication following radiosurgery of a pituitary adenoma is hypopituitarism. However, panhypopituitarism occurs only rarely in patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vance ML. Treatment of patients with a pituitary adenoma: one clinician’s experience. Neurosurg Focus. 2004;16:E1.
Walton L, Hampshire A, Roper A, Mitchell P, Vaughan P, Forster DM, et al. Development of a relocatable frame technique for Gamma Knife radiosurgery. Technical note. J Neurosurg. 2000;93(Suppl 3):198–202.
Hayashi M, Taira T, Chernov M, Fukuoka S, Liscak R, Yu CP, et al. Gamma Knife surgery for cancer pain-pituitary gland-stalk ablation: a multicenter prospective protocol since 2002. J Neurosurg. 2002;97:433–7.
Iwata H, Sato K, Tatewaki K, Yokota N, Inoue M, Baba Y, et al. Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity. Neuro-Oncology. 2011;13:916–22.
Liscak R, Vladyka V, Marek J, Simonova G, Vymazal J. Gamma Knife radiosurgery for endocrine-inactive pituitary adenomas. Acta Neurochir. 2007;149:999–1006. discussion 1006.
Park KJ, Kano H, Parry PV, Niranjan A, Flickinger JC, Lunsford LD, et al. Long-term outcomes after Gamma Knife stereotactic radiosurgery for nonfunctional pituitary adenomas. Neurosurgery. 2011;69:1188–99.
Sheehan JP, Starke RM, Mathieu D, Young B, Sneed PK, Chiang VL, et al. Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study. J Neurosurg. 2013;119:446–56.
Starke RM, Williams BJ, Jane JA Jr, Sheehan JP. Gamma Knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism. J Neurosurg. 2012;117:129–35.
Castinetti F, Nagai M, Dufour H, Kuhn JM, Morange I, Jaquet P, et al. Gamma Knife radiosurgery is a successful adjunctive treatment in Cushing’s disease. Eur J Endocrinol. 2007;156:91–8.
Devin JK, Allen GS, Cmelak AJ, Duggan DM, Blevins LS. The efficacy of linear accelerator radiosurgery in the management of patients with Cushing’s disease. Stereotact Funct Neurosurg. 2004;82:254–62.
Jagannathan J, Sheehan JP, Pouratian N, Laws ER, Steiner L, Vance ML. Gamma Knife surgery for Cushing’s disease. J Neurosurg. 2007;106:980–7.
Kobayashi T. Long-term results of stereotactic Gamma Knife radiosurgery for pituitary adenomas. Specific strategies for different types of adenoma. Prog Neurol Surg. 2009;22:77–95.
Sheehan JP, Xu Z, Salvetti DJ, Schmitt PJ, Vance ML. Results of Gamma Knife surgery for Cushing’s disease. J Neurosurg. 2013;119(6):1486–92.
Wan H, Chihiro O, Yuan S. MASEP Gamma Knife radiosurgery for secretory pituitary adenomas: experience in 347 consecutive cases. J Exp Clin Cancer Res. 2009;28:36.
Lee CC, Vance ML, Xu Z, Yen CP, Schlesinger D, Dodson B, et al. Stereotactic radiosurgery for acromegaly. J Clin Endocrinol Metab. 2014;99:1273–81.
Castinetti F, Taieb D, Kuhn JM, Chanson P, Tamura M, Jaquet P, et al. Outcome of Gamma Knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. J Clin Endocrinol Metab. 2005;90:4483–8.
Franzin A, Spatola G, Losa M, Picozzi P, Mortini P. Results of Gamma Knife radiosurgery in acromegaly. Int J Endocrinol. 2012;2012:342034.
Jezkova J, Marek J, Hana V, Krsek M, Weiss V, Vladyka V, et al. Gamma Knife radiosurgery for acromegaly – long-term experience. Clin Endocrinol. 2006;64:588–95.
Losa M, Gioia L, Picozzi P, Franzin A, Valle M, Giovanelli M, et al. The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma. J Clin Endocrinol Metab. 2008;93:2546–52.
Sheehan JP, Pouratian N, Steiner L, Laws ER, Vance ML. Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg. 2011;114:303–9.
Loeffler JS, Shih HA. Radiation therapy in the management of pituitary adenomas. J Clin Endocrinol Metab. 2011;96:1992–2003.
Jezkova J, Hana V, Krsek M, Weiss V, Vladyka V, Liscak R, et al. Use of the Leksell Gamma Knife in the treatment of prolactinoma patients. Clin Endocrinol. 2009;70:732–41.
Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, et al. Octreotide may act as a radioprotective agent in acromegaly. J Clin Endocrinol Metab. 2000;85:1287–9.
Liu X, Kano H, Kondziolka D, Park KJ, Iyer A, Shin S, et al. Gamma Knife stereotactic radiosurgery for drug resistant or intolerant invasive prolactinomas. Pituitary. 2013;16:68–75.
Pan L, Zhang N, Wang EM, Wang BJ, Dai JZ, Cai PW. Gamma Knife radiosurgery as a primary treatment for prolactinomas. J Neurosurg. 2000;93(Suppl 3):10–3.
Pouratian N, Sheehan J, Jagannathan J, Laws ER Jr, Steiner L, Vance ML. Gamma Knife radiosurgery for medically and surgically refractory prolactinomas. Neurosurgery. 2006;59:255–66. discussion 255–266.
Tanaka S, Link MJ, Brown PD, Stafford SL, Young WF Jr, Pollock BE. Gamma Knife radiosurgery for patients with prolactin-secreting pituitary adenomas. World Neurosurg. 2010;74:147–52.
Zhang N, Pan L, Wang EM, Dai JZ, Wang BJ, Cai PW. Radiosurgery for growth hormone-producing pituitary adenomas. J Neurosurg. 2000;93(Suppl 3):6–9.
Witt TC. Stereotactic radiosurgery for pituitary tumors. Neurosurg Focus. 2003;14:e10.
Landolt AM, Lomax N. Gamma Knife radiosurgery for prolactinomas. J Neurosurg. 2000;93(Suppl 3):14–8.
Gutt B, Wowra B, Alexandrov R, Uhl E, Schaaf L, Stalla GK, et al. Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly. Exp Clin Endocrinol Diabetes. 2005;113:219–24.
Jagannathan J, Sheehan JP, Pouratian N, Laws ER Jr, Steiner L, Vance ML. Gamma Knife radiosurgery for acromegaly: outcomes after failed transsphenoidal surgery. Neurosurgery. 2008;62:1262–9. discussion 1269–1270.
Xu Z, Lee Vance M, Schlesinger D, Sheehan JP. Hypopituitarism after stereotactic radiosurgery for pituitary adenomas. Neurosurgery. 2013;72:630–7.
Brada M, Ashley S, Ford D, Traish D, Burchell L, Rajan B. Cerebrovascular mortality in patients with pituitary adenoma. Clin Endocrinol. 2002;57:713–7.
Brada M, Burchell L, Ashley S, Traish D. The incidence of cerebrovascular accidents in patients with pituitary adenoma. Int J Radiat Oncol Biol Phys. 1999;45:693–8.
Brada M, Ford D, Ashley S, Bliss JM, Crowley S, Mason M, et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ. 1992;304:1343–6.
Minniti G, Osti M, Jaffrain-Rea ML, Esposito V, Cantore G, Maurizi Enrici R. Long-term follow-up results of postoperative radiation therapy for Cushing’s disease. J Neuro-Oncol. 2007;84:79–84.
Buatti JM, Friedman WA, Meeks SL, Bova FJ. The radiobiology of radiosurgery and stereotactic radiotherapy. Med Dosim. 1998;23:201–7.
Rowe J, Grainger A, Walton L, Silcocks P, Radatz M, Kemeny A. Risk of malignancy after Gamma Knife stereotactic radiosurgery. Neurosurgery. 2007;60:60–5. discussion 65–66.
Lim YJ, Leem W, Park JT, Kim TS, Rhee BA, Kim GK. Cerebral infarction with ICA occlusion after Gamma Knife radiosurgery for pituitary adenoma: a case report. Stereotact Funct Neurosurg. 1999;72(Suppl 1):132–9.
Lee CC, Kano H, Yang HC, Xu Z, Yen CP, Chung WY, et al. Initial Gamma Knife radiosurgery for nonfunctioning pituitary adenomas. J Neurosurg. 2014;120:647–54.
Xu Z, Ellis S, Lee CC, Starke RM, Schlesinger D, Lee Vance M, et al. Silent corticotroph adenomas following Gamma Knife radiosurgery. International journal of radiation oncology biology and physics. Int J Radiat Oncol Biol Phys. 2014;90(4):903–10.
Lee CC, Vance ML, Lopes MB, Xu Z, Chen CJ, Sheehan J. Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype. Pituitary. 2015;18:326–34.
Pollock BE, Nippoldt TB, Stafford SL, Foote RL, Abboud CF. Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization. J Neurosurg. 2002;97:525–30.
Ludecke DK, Flitsch J, Knappe UJ, Saeger W. Cushing’s disease: a surgical view. J Neuro-Oncol. 2001;54:151–66.
Chee GH, Mathias DB, James RA, Kendall-Taylor P. Transsphenoidal pituitary surgery in Cushing’s disease: can we predict outcome? Clin Endocrinol. 2001;54:617–26.
Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F. Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study. Study Group of the Italian Society of endocrinology on the pathophysiology of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab. 1999;84:440–8.
Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M. Risk factors and long-term outcome in pituitary-dependent Cushing’s disease. J Clin Endocrinol Metab. 1996;81:2647–52.
Yap LB, Turner HE, Adams CB, Wass JA. Undetectable postoperative cortisol does not always predict long-term remission in Cushing’s disease: a single centre audit. Clin Endocrinol. 2002;56:25–31.
Lee CC, Chen CJ, Yen CP, Xu Z, Schlesinger D, Fezeu F, et al. Whole-sellar stereotactic radiosurgery for functioning pituitary adenomas. Neurosurgery. 2014;75:227–37. discussion 237.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lee, Cc., Trifiletti, D.M., Sheehan, J.P. (2019). Stereotactic Radiosurgery for Pituitary Adenoma. In: Trifiletti, D., Chao, S., Sahgal, A., Sheehan, J. (eds) Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy. Springer, Cham. https://doi.org/10.1007/978-3-030-16924-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-16924-4_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16923-7
Online ISBN: 978-3-030-16924-4
eBook Packages: MedicineMedicine (R0)